The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Mood Disorder Treatment-Global Market Insights and Sales Trends 2024

Mood Disorder Treatment-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1871829

No of Pages : 104

Synopsis
Mood disorder treatment refers to the interventions and strategies used to manage and alleviate the symptoms of mood disorders, which are mental health conditions characterized by disturbances in mood, such as depression or bipolar disorder. The goal of treatment is to reduce symptoms, improve functioning, and enhance the overall quality of life for individuals affected by mood disorders.
The global Mood Disorder Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Mood Disorder Treatment in various end use industries. The expanding demands from the Hospital, Specialty Clinic and Others,, are propelling Mood Disorder Treatment market. Medications, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Psychotherapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mood Disorder Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mood Disorder Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mood Disorder Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mood Disorder Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mood Disorder Treatment covered in this report include MECTA Corporation, Ectron Limited, Somatics, LLC., Alkermes, Eli Lilly and Company, Janssen Global Services, LLC (Johnson & Johnson), Allergan (AbbVie Inc.), Pfizer Inc. and Mylan N.V., etc.
The global Mood Disorder Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
MECTA Corporation
Ectron Limited
Somatics, LLC.
Alkermes
Eli Lilly and Company
Janssen Global Services, LLC (Johnson & Johnson)
Allergan (AbbVie Inc.)
Pfizer Inc.
Mylan N.V.
Novartis AG
Global Mood Disorder Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mood Disorder Treatment market, Segment by Type:
Medications
Psychotherapy
Brain Stimulation Therapies
Global Mood Disorder Treatment market, by Application
Hospital
Specialty Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Mood Disorder Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Mood Disorder Treatment
1.1 Mood Disorder Treatment Market Overview
1.1.1 Mood Disorder Treatment Product Scope
1.1.2 Mood Disorder Treatment Market Status and Outlook
1.2 Global Mood Disorder Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Mood Disorder Treatment Market Size by Region (2018-2029)
1.4 Global Mood Disorder Treatment Historic Market Size by Region (2018-2023)
1.5 Global Mood Disorder Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Mood Disorder Treatment Market Size (2018-2029)
1.6.1 North America Mood Disorder Treatment Market Size (2018-2029)
1.6.2 Europe Mood Disorder Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Mood Disorder Treatment Market Size (2018-2029)
1.6.4 Latin America Mood Disorder Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Mood Disorder Treatment Market Size (2018-2029)
2 Mood Disorder Treatment Market by Type
2.1 Introduction
2.1.1 Medications
2.1.2 Psychotherapy
2.1.3 Brain Stimulation Therapies
2.2 Global Mood Disorder Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Mood Disorder Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Mood Disorder Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Mood Disorder Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Mood Disorder Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Mood Disorder Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Mood Disorder Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Mood Disorder Treatment Revenue Breakdown by Type (2018-2029)
3 Mood Disorder Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Specialty Clinic
3.1.3 Others
3.2 Global Mood Disorder Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Mood Disorder Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Mood Disorder Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Mood Disorder Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Mood Disorder Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Mood Disorder Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Mood Disorder Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Mood Disorder Treatment Revenue Breakdown by Application (2018-2029)
4 Mood Disorder Treatment Competition Analysis by Players
4.1 Global Mood Disorder Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mood Disorder Treatment as of 2022)
4.3 Date of Key Players Enter into Mood Disorder Treatment Market
4.4 Global Top Players Mood Disorder Treatment Headquarters and Area Served
4.5 Key Players Mood Disorder Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Mood Disorder Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 MECTA Corporation
5.1.1 MECTA Corporation Profile
5.1.2 MECTA Corporation Main Business
5.1.3 MECTA Corporation Mood Disorder Treatment Products, Services and Solutions
5.1.4 MECTA Corporation Mood Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 MECTA Corporation Recent Developments
5.2 Ectron Limited
5.2.1 Ectron Limited Profile
5.2.2 Ectron Limited Main Business
5.2.3 Ectron Limited Mood Disorder Treatment Products, Services and Solutions
5.2.4 Ectron Limited Mood Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Ectron Limited Recent Developments
5.3 Somatics, LLC.
5.3.1 Somatics, LLC. Profile
5.3.2 Somatics, LLC. Main Business
5.3.3 Somatics, LLC. Mood Disorder Treatment Products, Services and Solutions
5.3.4 Somatics, LLC. Mood Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Alkermes Recent Developments
5.4 Alkermes
5.4.1 Alkermes Profile
5.4.2 Alkermes Main Business
5.4.3 Alkermes Mood Disorder Treatment Products, Services and Solutions
5.4.4 Alkermes Mood Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Alkermes Recent Developments
5.5 Eli Lilly and Company
5.5.1 Eli Lilly and Company Profile
5.5.2 Eli Lilly and Company Main Business
5.5.3 Eli Lilly and Company Mood Disorder Treatment Products, Services and Solutions
5.5.4 Eli Lilly and Company Mood Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Eli Lilly and Company Recent Developments
5.6 Janssen Global Services, LLC (Johnson & Johnson)
5.6.1 Janssen Global Services, LLC (Johnson & Johnson) Profile
5.6.2 Janssen Global Services, LLC (Johnson & Johnson) Main Business
5.6.3 Janssen Global Services, LLC (Johnson & Johnson) Mood Disorder Treatment Products, Services and Solutions
5.6.4 Janssen Global Services, LLC (Johnson & Johnson) Mood Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Janssen Global Services, LLC (Johnson & Johnson) Recent Developments
5.7 Allergan (AbbVie Inc.)
5.7.1 Allergan (AbbVie Inc.) Profile
5.7.2 Allergan (AbbVie Inc.) Main Business
5.7.3 Allergan (AbbVie Inc.) Mood Disorder Treatment Products, Services and Solutions
5.7.4 Allergan (AbbVie Inc.) Mood Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Allergan (AbbVie Inc.) Recent Developments
5.8 Pfizer Inc.
5.8.1 Pfizer Inc. Profile
5.8.2 Pfizer Inc. Main Business
5.8.3 Pfizer Inc. Mood Disorder Treatment Products, Services and Solutions
5.8.4 Pfizer Inc. Mood Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Pfizer Inc. Recent Developments
5.9 Mylan N.V.
5.9.1 Mylan N.V. Profile
5.9.2 Mylan N.V. Main Business
5.9.3 Mylan N.V. Mood Disorder Treatment Products, Services and Solutions
5.9.4 Mylan N.V. Mood Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Mylan N.V. Recent Developments
5.10 Novartis AG
5.10.1 Novartis AG Profile
5.10.2 Novartis AG Main Business
5.10.3 Novartis AG Mood Disorder Treatment Products, Services and Solutions
5.10.4 Novartis AG Mood Disorder Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Novartis AG Recent Developments
6 North America
6.1 North America Mood Disorder Treatment Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Mood Disorder Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Mood Disorder Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Mood Disorder Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Mood Disorder Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Mood Disorder Treatment Market Dynamics
11.1 Mood Disorder Treatment Industry Trends
11.2 Mood Disorder Treatment Market Drivers
11.3 Mood Disorder Treatment Market Challenges
11.4 Mood Disorder Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’